First Time Loading...

CellaVision AB
OTC:CLVSF

Watchlist Manager
CellaVision AB Logo
CellaVision AB
OTC:CLVSF
Watchlist
Price: 20.36 USD
Updated: Apr 19, 2024

Intrinsic Value

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. [ Read More ]

The intrinsic value of one CLVSF stock under the Base Case scenario is 24.86 USD. Compared to the current market price of 20.36 USD, CellaVision AB is Undervalued by 18%.

Key Points:
CLVSF Intrinsic Value
Base Case
24.86 USD
Undervaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
CellaVision AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CLVSF stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
CellaVision AB

Provide an overview of the primary business activities
of CellaVision AB.

What unique competitive advantages
does CellaVision AB hold over its rivals?

What risks and challenges
does CellaVision AB face in the near future?

Summarize the latest earnings call
of CellaVision AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CellaVision AB.

Provide P/S
for CellaVision AB.

Provide P/E
for CellaVision AB.

Provide P/OCF
for CellaVision AB.

Provide P/FCFE
for CellaVision AB.

Provide P/B
for CellaVision AB.

Provide EV/S
for CellaVision AB.

Provide EV/GP
for CellaVision AB.

Provide EV/EBITDA
for CellaVision AB.

Provide EV/EBIT
for CellaVision AB.

Provide EV/OCF
for CellaVision AB.

Provide EV/FCFF
for CellaVision AB.

Provide EV/IC
for CellaVision AB.

Show me price targets
for CellaVision AB made by professional analysts.

What are the Revenue projections
for CellaVision AB?

How accurate were the past Revenue estimates
for CellaVision AB?

What are the Net Income projections
for CellaVision AB?

How accurate were the past Net Income estimates
for CellaVision AB?

What are the EPS projections
for CellaVision AB?

How accurate were the past EPS estimates
for CellaVision AB?

What are the EBIT projections
for CellaVision AB?

How accurate were the past EBIT estimates
for CellaVision AB?

Compare the revenue forecasts
for CellaVision AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CellaVision AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CellaVision AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of CellaVision AB compared to its peers.

Compare the P/E ratios
of CellaVision AB against its peers.

Discuss the investment returns and shareholder value creation
comparing CellaVision AB with its peers.

Analyze the financial leverage
of CellaVision AB compared to its main competitors.

Show all profitability ratios
for CellaVision AB.

Provide ROE
for CellaVision AB.

Provide ROA
for CellaVision AB.

Provide ROIC
for CellaVision AB.

Provide ROCE
for CellaVision AB.

Provide Gross Margin
for CellaVision AB.

Provide Operating Margin
for CellaVision AB.

Provide Net Margin
for CellaVision AB.

Provide FCF Margin
for CellaVision AB.

Show all solvency ratios
for CellaVision AB.

Provide D/E Ratio
for CellaVision AB.

Provide D/A Ratio
for CellaVision AB.

Provide Interest Coverage Ratio
for CellaVision AB.

Provide Altman Z-Score Ratio
for CellaVision AB.

Provide Quick Ratio
for CellaVision AB.

Provide Current Ratio
for CellaVision AB.

Provide Cash Ratio
for CellaVision AB.

What is the historical Revenue growth
over the last 5 years for CellaVision AB?

What is the historical Net Income growth
over the last 5 years for CellaVision AB?

What is the current Free Cash Flow
of CellaVision AB?

Financials

Balance Sheet Decomposition
CellaVision AB

Current Assets 365.6m
Cash & Short-Term Investments 121.6m
Receivables 117.9m
Other Current Assets 126m
Non-Current Assets 563.1m
Long-Term Investments 4.4m
PP&E 125.5m
Intangibles 433.2m
Other Non-Current Assets 1k
Current Liabilities 119.2m
Accounts Payable 32.5m
Other Current Liabilities 86.6m
Non-Current Liabilities 93.2m
Long-Term Debt 28.7m
Other Non-Current Liabilities 64.5m
Efficiency

Earnings Waterfall
CellaVision AB

Revenue
677.3m SEK
Cost of Revenue
-214.3m SEK
Gross Profit
463m SEK
Operating Expenses
-296m SEK
Operating Income
167.1m SEK
Other Expenses
-36.7m SEK
Net Income
130.3m SEK

Free Cash Flow Analysis
CellaVision AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

CLVSF Profitability Score
Profitability Due Diligence

CellaVision AB's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Free Cash Flow
Positive Operating Income
65/100
Profitability
Score

CellaVision AB's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

CLVSF Solvency Score
Solvency Due Diligence

CellaVision AB's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
85/100
Solvency
Score

CellaVision AB's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CLVSF Price Targets Summary
CellaVision AB

Wall Street analysts forecast CLVSF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLVSF is 24.7 USD with a low forecast of 22.43 USD and a high forecast of 29.15 USD.

Lowest
Price Target
22.43 USD
10% Upside
Average
Price Target
24.7 USD
21% Upside
Highest
Price Target
29.15 USD
43% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

CEVI Price
CellaVision AB

1M 1M
-5%
6M 6M
+79%
1Y 1Y
+45%
3Y 3Y
-37%
5Y 5Y
-28%
10Y 10Y
+1 075%
Annual Price Range
220
52w Low
122.8
52w High
268.5
Price Metrics
Average Annual Return -5.33%
Standard Deviation of Annual Returns 14.61%
Max Drawdown -75%
Shares Statistics
Market Capitalization 5.2B SEK
Shares Outstanding 23 851 500
Percentage of Shares Shorted
N/A

CEVI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

CellaVision AB Logo
CellaVision AB

Country

Sweden

Industry

Health Care

Market Cap

5.2B USD

Dividend Yield

1.05%

Description

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

Contact

SKANE
Lund
Mobilvagen 12
+46464601600.0
http://www.cellavision.com/

IPO

2007-05-28

Employees

200

Officers

Founder & Director
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
CEO & President
Mr. Simon Ostergaard
Chief Financial Officer
Mr. Magnus Blixt
Vice President of Global Marketing
Mr. Peter Wilson
Vice President of Global Sales
Mr. Urban Strindlov
Vice President of Human Resources
Nina Wallander

See Also

Discover More
What is the Intrinsic Value of one CLVSF stock?

The intrinsic value of one CLVSF stock under the Base Case scenario is 24.86 USD.

Is CLVSF stock undervalued or overvalued?

Compared to the current market price of 20.36 USD, CellaVision AB is Undervalued by 18%.